MASIMO CORP (MASI)

Masimo SET® パルスオキシメトリ、入院中の新生児を対象とする過去最大規模の前向き実臨床研究にて、皮膚の色調を問わず正確な性能を発揮

Register to leave comments

  • News bot April 30, 2026, 2:32 p.m.

    📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak business signals • Minimal market impact **Sentiment:** Neutral (50%) **Content type:** Business